Bone Involvement in Eugonadal Male Patients with Adrenal Incidentaloma and Subclinical Hypercortisolism
Iacopo Chiodini,
Libuse Tauchmanovà,
Massimo Torlontano,
Claudia Battista,
Giuseppe Guglielmi,
Mario Cammisa,
Annamaria Colao,
Vincenzo Carnevale,
Riccardo Rossi,
Sergio Di Lembo,
Vincenzo Trischitta and
Alfredo Scillitani
Units of Endocrinology (I.C., M.T., C.B., V.T., A.S.), Radiology (G.G., M.C.), and Internal Medicine (V.C.), Scientific Institute Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo (Foggia), Italy; Unit of Endocrinology (I.C., S.D.L.), San Giuseppe-Fatebenefratelli Hospital, Fatebenefratelli Association for Research, 20123 Milano, Italy; Unit of Endocrinology (L.T., A.C., R.R.), "Federico II" University, 80129 Napoli, Italy; and Department of Clinical Sciences (V.T.), "La Sapienza" University, 00498 Rome, Italy
Address all correspondence and requests for reprints to: Alfredo Scillitani, M.D., Unit of Endocrinology, Scientific Institute Casa Sollievo della Sofferenza, Viale Cappuccini, 71013 San Giovanni Rotondo (Foggia), Italy. E-mail: endocrino{at}operapadrepio.it.
Abstract
Adrenal incidentalomas (AI) are not associated, by definition,with clinically evident syndromes; however, some AI patientsmay show biochemical indexes of subclinical hypercortisolism(SH). Previous data on female AI patients indicated that SHmay lead to bone loss, at least at spine. No data are availableon bone involvement in samples of only AI male patients.
We measured bone metabolism and bone mineral density at spineand femur by dual-energy x-ray absorptiometry in 38 consecutiveeugonadal male AI patients and 38 healthy matched control subjects.Patients were subdivided according to the presence or absenceof SH (group SH+ and group SH-, respectively). Mean Z-scorelevels of spinal bone mineral density measured by dual-energyx-ray absorptiometry were lower (P < 0.05) in group SH+ (-0.42± 1.62) in comparison with group SH- (0.6 ± 1.13)and controls (0.47 ± 1.06). Thus, in order for the mostappropriate management to be individually tailored, bone massevaluation is strongly indicated in AI male patients with SH,irrespective of their gonadal status.
This article has been cited by other articles:
C. Eller-Vainicher, V. Morelli, A. S. Salcuni, M. Torlontano, F. Coletti, L. Iorio, A. Cuttitta, A. Ambrosio, L. Vicentini, V. Carnevale, et al. Post-surgical hypocortisolism after removal of an adrenal incidentaloma: is it predictable by an accurate endocrinological work-up before surgery?
Eur. J. Endocrinol.,
January 1, 2010;
162(1):
91 - 99.
[Abstract][Full Text][PDF]
I. Chiodini, V. Morelli, B. Masserini, A. S. Salcuni, C. Eller-Vainicher, R. Viti, F. Coletti, G. Guglielmi, C. Battista, V. Carnevale, et al. Bone Mineral Density, Prevalence of Vertebral Fractures, and Bone Quality in Patients with Adrenal Incidentalomas with and without Subclinical Hypercortisolism: An Italian Multicenter Study
J. Clin. Endocrinol. Metab.,
September 1, 2009;
94(9):
3207 - 3214.
[Abstract][Full Text][PDF]
B. Masserini, V. Morelli, S. Bergamaschi, F. Ermetici, C. Eller-Vainicher, A. M. Barbieri, M. A. Maffini, A. Scillitani, B. Ambrosi, P. Beck-Peccoz, et al. The limited role of midnight salivary cortisol levels in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentaloma
Eur. J. Endocrinol.,
January 1, 2009;
160(1):
87 - 92.
[Abstract][Full Text][PDF]
I. Chiodini, M. L. Mascia, S. Muscarella, C. Battista, S. Minisola, M. Arosio, S. A. Santini, G. Guglielmi, V. Carnevale, and A. Scillitani Subclinical Hypercortisolism among Outpatients Referred for Osteoporosis
Ann Intern Med,
October 16, 2007;
147(8):
541 - 548.
[Abstract][Full Text][PDF]
W. F. Young Jr. The Incidentally Discovered Adrenal Mass
N. Engl. J. Med.,
February 8, 2007;
356(6):
601 - 610.
[Full Text][PDF]
I. Chiodini, G. Guglielmi, C. Battista, V. Carnevale, M. Torlontano, M. Cammisa, V. Trischitta, and A. Scillitani Spinal Volumetric Bone Mineral Density and Vertebral Fractures in Female Patients with Adrenal Incidentalomas: The Effects of Subclinical Hypercortisolism and Gonadal Status
J. Clin. Endocrinol. Metab.,
May 1, 2004;
89(5):
2237 - 2241.
[Abstract][Full Text][PDF]
G. D. Braunstein and for the National Institutes of Health State-of-the Management of the Clinically Inapparent Adrenal Mass
Ann Intern Med,
March 2, 2004;
140(5):
401 - 402.
[Full Text][PDF]